Page last updated: 2024-10-29

ketamine and Female Genitourinary Diseases

ketamine has been researched along with Female Genitourinary Diseases in 3 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, PS1
Cheung, RY1
Chan, SS1
Lee, JH1
Pang, AW1
Choy, KW1
Chung, TK1
Wei, YB1
Yang, JR1

Other Studies

3 other studies available for ketamine and Female Genitourinary Diseases

ArticleYear
Persistence of urinary symptoms after cessation of ketamine abuse.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2011, Volume: 17, Issue:4

    Topics: Excitatory Amino Acid Antagonists; Female; Female Urogenital Diseases; Humans; Ketamine; Quality of

2011
Urinary symptoms and impaired quality of life in female ketamine users: persistence after cessation of use.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2011, Volume: 17, Issue:4

    Topics: Body Mass Index; Excitatory Amino Acid Antagonists; Female; Female Urogenital Diseases; Humans; Keta

2011
Moxifloxacin relieves the persistent symptoms of lower urinary tract after cessation of ketamine abuse.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2011, Volume: 17, Issue:6

    Topics: Excitatory Amino Acid Antagonists; Female; Female Urogenital Diseases; Humans; Ketamine; Quality of

2011